Alzheimer's disease has long been thought to be irreversible, but new research using a mouse model offers hope.

Alzheimer’s disease (AD) and cancer both represent diseases that classically occur in older individuals.  However, these diseases rarely occur i | Cancer ...

Highlights from CTAD 2025 include GLP-1 agonist data, p-tau217 biomarker utility, subcutaneous lecanemab trials, and racial disparities in trial enrollment.

Alzheimer’s disease (AD) can be devastating for patients and their families and is a significant public health concern for society. Eisai’s commitment to Alzheimer’s drug discovery spans over four ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as two-year clinical trials end in disappointment for patients, medical ...

In the largest analysis yet of Alzheimer’s disease (AD) gene activity in brain tissue from African American donors, researchers identified more than 400 genes expressed differently in those with AD, ...